| Current Price | $200.38 | Mkt Cap | $52.4B |
|---|---|---|---|
| Open | $202.73 | P/E Ratio | 19.02 |
| Prev. Close | $200.38 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $198.83 - $202.94 | Volume | 1,392,573 |
| 52-Wk Range | $185.33 - $283.45 | Avg. Daily Vol. | 2,661,905 |
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
| Current Price | $200.38 | Mkt Cap | $52.4B |
|---|---|---|---|
| Open | $202.73 | P/E Ratio | 19.02 |
| Prev. Close | $200.38 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $198.83 - $202.94 | Volume | 1,392,573 |
| 52-Wk Range | $185.33 - $283.45 | Avg. Daily Vol. | 2,661,905 |
The best Bull and Bear pitches based on recency and number of recommendations.
-Bullishness on gene therapy segment and partnership w/ CRISPR-Strength in Cystic Fibrosis treatment (Dominant, but large part of US TAM left to capture)-Research methodology/product development strategy-Current valuation and multiples. ($55Bn,… More
9/26/14 DOWN TO UP = <30.04> 7/19/16 = UP TO DOWN
Read the most recent pitches from players about VRTX.
Recs
TMFRetireFoolish
(26.25)
Submitted: 7/17/2021 11:04:18 AM :
Start Price:
$200.60
NASDAQ:VRTX Score:
-3.50
Highly profitable cystic fibrosis franchise generating $3 billion in FCF and funding investments for next blockbuster
Recs
TMFjbonefish
(67.09)
Submitted: 7/13/2021 5:16:56 PM :
Start Price:
$197.51
NASDAQ:VRTX Score:
+0.71
It owns cystic fibrosis and is partnering to develop a next-generation gene therapy. It may lag in the near term, but the cash cow should allow it develop or acquire strategic assets that drive growth. In the meantime, it's cheap.
Recs
CMFJoeFoolery
(< 20)
Submitted: 4/5/2021 4:38:48 PM :
Start Price:
$215.50
NASDAQ:VRTX Score:
-15.61
-Bullishness on gene therapy segment and partnership w/ CRISPR
-Strength in Cystic Fibrosis treatment (Dominant, but large part of US TAM left to capture)
-Research methodology/product development strategy
-Current valuation and multiples. ($55Bn, attractive growth in revenue and net income the past few yrs, plenty of cash on hand)
Find the members with the highest scoring picks in VRTX.
bugeyebear (34.81) Score: +1,012.71
The Score Leader is the player with the highest score across all their picks in VRTX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| bugeyebear | 34.81 | 3/17/2008 |
|
3Y | $14.60 | +1,272.47% | +259.75% | +1,012.71 | 0 Comment | |
| lostontheprairie | 67.92 | 3/12/2008 |
|
5Y | $14.99 | +1,236.76% | +245.98% | +990.78 | 0 Comment | |
| Kudude | 62.84 | 3/12/2008 |
|
5Y | $14.99 | +1,236.76% | +245.98% | +990.78 | 0 Comment | |
| Salilp | 73.18 | 3/17/2008 |
|
5Y | $15.07 | +1,229.66% | +262.82% | +966.84 | 0 Comment | |
| davidmouw2 | < 20 | 3/14/2008 |
|
NS | $15.43 | +1,198.64% | +245.87% | +952.77 | 0 Comment | |
|
snazzysnazz | 71.44 | 3/13/2008 |
|
5Y | $15.49 | +1,193.61% | +254.33% | +939.28 | 0 Comment |
| NovaMechanika | 24.78 | 3/20/2008 |
|
3Y | $15.55 | +1,188.62% | +251.39% | +937.23 | 2 Comments | |
| stnewbie | 40.27 | 3/12/2008 |
|
NS | $15.78 | +1,169.84% | +247.55% | +922.29 | 0 Comment | |
| PrincetonAl | 86.11 | 3/7/2008 |
|
3Y | $15.86 | +1,163.43% | +254.27% | +909.16 | 1 Comment | |
|
|
hayrettin | 72.25 | 3/24/2008 |
|
5Y | $16.47 | +1,116.64% | +242.78% | +873.85 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
